| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Jack Higgins is Chief Scientific Officer at IMNM. Jack Higgins's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.1M at current prices.
The IMNM filings lean toward selling, a net 26,162 shares.
Jack Higgins has 11 Form 4 filings on record from December 2023 to September 2026, all as Chief Scientific Officer at Immunome (IMNM), 2023–2026.
The 21 reported transactions were 9 gifts, 4 option exercises, 4 option or other derivative awards and 3 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $588K.
The largest open-market sale was 13,200 shares of IMNM at an average $25.32 on September 11, 2026, about $334K.
2 of the 3 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | IMNM Immunome, Inc. | Chief Scientific Officer | Sale+OE10b5-1 | 13,200 | $25.32 | $334,224.00 | -16.9% | - | - | |
| Apr 2, 2026 | IMNM Immunome, Inc. | Chief Scientific Officer | Sell10b5-1 | 9,438 | $21.64 | $204,238.32 | -30.0% | -1.6% | - | |
| Aug 15, 2024 | IMNM Immunome Inc. | Chief Scientific Officer | Sale+OE | 3,524 | $13.93 | $49,071.70 | -18.0% | -16.9% | -26.3% |